most critical steps in vaccine development is the selection of appropriate antigens and their proper introduction into the immune system. Therefore, in this study, we …

K Yoo, J Song, L Park, H Shin - … in the Pathogenesis of COVID-19, 2023 - books.google.com
The recent and ongoing pandemic named COVID-19 caused by the coronavirus SARS-CoV-
2 that first emerged in late 2019 continues to claim over 6 billion positive cases with higher …

[HTML][HTML] COVID-19 spike polypeptide vaccine reduces the pathogenesis and viral infection in a mouse model of SARS-CoV-2

Y Hisham, SM Seo, S Kim, S Shim, J Hwang… - Frontiers in …, 2023 - frontiersin.org
The SARS-CoV-2 coronavirus, which causes a respiratory disease called COVID-19, has
been declared a pandemic by the World Health Organization (WHO) and is still ongoing …

[HTML][HTML] Potential challenges for coronavirus (SARS-CoV-2) vaccines under trial

SS Usmani, GPS Raghava - Frontiers in Immunology, 2020 - frontiersin.org
Many vaccines are under clinical trials to fight against pandemic COVID-19. Here, we briefly
reviewed vaccines under trial and their limitations, with a possible alternate solution to …

Comprehensive literature review on COVID-19 vaccines and role of SARS-CoV-2 variants in the pandemic

C Yap, A Ali, A Prabhakar… - … in Vaccines and …, 2021 - journals.sagepub.com
Since the outbreak of the COVID-19 pandemic, there has been a rapid expansion in vaccine
research focusing on exploiting the novel discoveries on the pathophysiology, genomics …

[HTML][HTML] Mutation profile of SARS-CoV-2 spike protein and identification of potential multiple epitopes within spike protein for vaccine development against SARS-CoV …

D Paul, N Pyne, S Paul - Virusdisease, 2021 - Springer
The COVID-19 pandemic worldwide has resulted in over 176 million cases and roughly 3.8
million deaths so far. We could analyze mutation dynamics across the genome from …

Promise and challenges in the development of COVID-19 vaccines

W Chen - Human Vaccines & Immunotherapeutics, 2020 - Taylor & Francis
The pandemic outbreak of COVID-19, caused by coronavirus SARS-CoV-2, created an
unprecedented challenge to global public health system and biomedical community …

A snapshot of different types of under research vaccines against COVID-19: a review

M Zandi, S Rashid, S Nasimzadeh… - Archives of Medical …, 2020 - journals.sbmu.ac.ir
SARS-CoV-2 as an emerging coronavirus, which first emerged in late 2019 in China causes
a respiratory disease called “Coronavirus Disease 2019 (COVID-19)''. SARS-CoV-2 has …

[HTML][HTML] SARS-CoV-2 targets and COVID-19 vaccines

AW Currier, MC Jeshurin, VB Sampson - COVID, 2021 - mdpi.com
Coronavirus disease-2019 (COVID-19) vaccines are being used across the globe to reduce
the risk of developing COVID-19, stop the transmission of severe acute respiratory syndrome …

[PDF][PDF] WAYS OF MAKING EFFECTIVE AND SAFE VACCINES AGAINST SARS-CoV-2

MS Reza, F Mim, MR Quader, MJR Khan, MS Hossain… - 2021 - researchgate.net
Severe acute respiratory syndrome (SARS) is an emerging infectious disease caused by
SARS–associated coronavirus (SARS-CoV). Severe Acute Respiratory Syndrome …

[HTML][HTML] Immune response to SARS-CoV-2 vaccines

N Bellamkonda, UP Lambe, S Sawant, SS Nandi… - Biomedicines, 2022 - mdpi.com
COVID-19 vaccines have been developed to confer immunity against the SARS-CoV-2
infection. Prior to the pandemic of COVID-19 which started in March 2020, there was a well …